Prescriptions for semaglutide and tirzepatide among patients with PCOS Between 2021 and 2025, 445,258 patients with PCOS had at least one medical encounter, of whom 90,206 (20.3%) received a semaglutide or tirzepatide prescription during the study period
Stevens, H., de la Paz, M., Cooper, B
In contrast, improvements in quality of life measures have been reported with incretin therapy
EHCNYC PROGRAM MEMBER Your Journey, Our Commitment 4.9/5 Trusted by Clients with a 4.9/5 rating Christopher Eliot Burnley I recently had the pleasure of working with Elite Health NYC on my weight loss journey, and I cannot recommend them highly enough
For any individual biotech company, an investment thesis encompasses much more (e.g